Specialty

Respiratory. Asthma, superficially it seems simple to manage and mild asthma would seem simple to identify, but the more you look, the more you find there are differences and variations in the clinical expression and physiology. In this interview we discuss how to tailor treatment to each individual patient.

Respiratory. In this interview we discuss a recent study, the IMPACT study, which has looked at exacerbations and all-cause mortality differences in a head to head study comparing a number of inhaler strategies. This is an important study which answers some really important clinical questions.

Epilepsy: Epilepsy is one of the most common neurological illnesses, affecting three to four per cent of people in the developing world, and while we have a wealth of treatment options, many of these are now very old. In this interview we focus on the treatment options available to us as physicians and look at what this means to the patient and what factors we ought to consider.
30-minute listen

Epilepsy: In Australia, up to 2,000 women on anti-epileptic drugs become pregnant each year but there is concern, particularly in the neurological community, about the possible risks for these drugs and their teratogenicity. Neurologists have to balance the risks of both seizures and the risks of the medications and striking a balance is difficult – listen to learn more.
38-minute listen

Endocrinology. In this interview we discuss cases which are less than typical, the sort of patients that we are often referred by general practitioners. We apply the evidence to; Migraine, VTE, BRCA 1 and 2, and premature ovarian insufficiency, all situations that we’re more likely to see in secondary care. 30-minute listen

Endocrinology: There’s been a spotlight on hormone therapy and breast cancer recently. Research is showing that women do not understand the long-term health consequences of menopause. So, what do we need to consider and how should we explain the multidimensional effects of menopause and of hormone therapy to our patients? 20-minute listen

Ophthalmology. Many patients either present with bilateral disease or progress when having the macula affected in one eye, to both eyes within a few years. The key clinical question is; how clinical practice should be adapted when moving from unilateral to bilateral anti-VEGF therapy. In this interview we discuss pragmatic considerations to reduce the burden of bilateral anti-VEGF injections while mitigating any additional risks.

Ophthalmology. Since the introduction of anti-VEGF therapies, real world outcomes have generally not been as good as those observed in the trials. The question is whether this is due to the use of reactive approaches to therapy or whether proactive approaches to therapy might actually be better, and is there any evidence for ophthalmologists moving to proactive therapy. We discuss some of these questions in this interview.

Respiratory. A lot has changed in the world of pulmonary fibrosis in the last few years, in terms of what treatments are available and what this means for our patients. We now have options to slow disease progression down and to prolong life, listen to learn more.

Respiratory. Idiopathic pulmonary fibrosis, the disease course can be unpredictable, progressing rapidly in some patients and quite slowly in others. Patients need to know about the diagnosis and the treatment, to be informed about survival and palliative care, and what life is going to be like. So at what point do you give this information?